AllianceBernstein’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
33,715
+18,555
+122% +$880K ﹤0.01% 2122
2026
Q1
$1.4M Sell
15,160
-15,476
-51% -$1.08M ﹤0.01% 2191
2025
Q4
$2.83M Buy
30,636
+23,863
+352% +$2.28M ﹤0.01% 1816
2025
Q3
$503K Buy
6,773
+346
+5% +$35K ﹤0.01% 2673
2025
Q2
$834K Sell
6,427
-4,494
-41% -$652K ﹤0.01% 2384
2025
Q1
$1.74M Buy
10,921
+3
+0% +$543 ﹤0.01% 1979
2024
Q4
$2.02M Sell
10,918
-106
-1% -$20.6K ﹤0.01% 1951
2024
Q3
$2.33M Buy
11,024
+1,215
+12% +$211K ﹤0.01% 1887
2024
Q2
$1.31M Buy
9,809
+103
+1% +$19.5K ﹤0.01% 2173
2024
Q1
$2.08M Buy
9,706
+239
+3% +$46.8K ﹤0.01% 1896
2023
Q4
$1.93M Buy
9,467
+384
+4% +$62.2K ﹤0.01% 1956
2023
Q3
$1.8M Sell
9,083
-56
-0.6% -$14.1K ﹤0.01% 1934
2023
Q2
$2.97M Sell
9,139
-25,576
-74% -$7.31M ﹤0.01% 1678
2023
Q1
$8.13M Hold
34,715
﹤0.01% 1182
2022
Q4
$8.74M Buy
34,715
+600
+2% +$128K ﹤0.01% 1165
2022
Q3
$6.05M Sell
34,115
-5
-0% -$1K ﹤0.01% 1316
2022
Q2
$6.23M Buy
34,120
+20
+0.1% +$3.99K ﹤0.01% 1358
2022
Q1
$8.75M Buy
34,100
+100
+0.3% +$22.9K ﹤0.01% 1308
2021
Q4
$7.82M Sell
34,000
-500
-1% -$122K ﹤0.01% 1387
2021
Q3
$8.03M Sell
34,500
-200
-0.6% -$41.7K ﹤0.01% 1364
2021
Q2
$6.71M Sell
34,700
-2,100
-6% -$416K ﹤0.01% 1444
2021
Q1
$7.62M Buy
36,800
+800
+2% +$170K ﹤0.01% 1342
2020
Q4
$6.77M Hold
36,000
﹤0.01% 1326
2020
Q3
$4.65M Sell
36,000
-900
-2% -$99.2K ﹤0.01% 1375
2020
Q2
$3.21M Buy
36,900
+16,600
+82% +$1.28M ﹤0.01% 1587
2020
Q1
$1.22M Sell
20,300
-1,000
-5% -$74K ﹤0.01% 1950
2019
Q4
$1.58M Hold
21,300
﹤0.01% 2082
2019
Q3
$1.3M Hold
21,300
﹤0.01% 2150
2019
Q2
$1.29M Buy
21,300
+9,500
+81% +$512K ﹤0.01% 2202
2019
Q1
$670K Hold
11,800
﹤0.01% 2415
2018
Q4
$499K Hold
11,800
﹤0.01% 2486
2018
Q3
$497K Buy
11,800
+4,300
+57% +$202K ﹤0.01% 2622
2018
Q2
$267K Buy
+7,500
New +$242K ﹤0.01% 2863

Other funds holding INSP

AllianceBernstein's INSP Position: Q2 2026 in Review

AllianceBernstein increased its Inspire Medical Systems (INSP) stake by 122% in Q2 2026, buying an estimated $880K and bringing the position to 33,715 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

AllianceBernstein first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.75M in Q1 2022. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • AllianceBernstein held 33,715 shares of Inspire Medical Systems worth $1.74M as of Q2 2026.
  • AllianceBernstein bought 18,555 Inspire Medical Systems shares in Q2 2026, an estimated $880K.
  • Inspire Medical Systems made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2122 holding.
  • AllianceBernstein first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
  • AllianceBernstein's Inspire Medical Systems position peaked at $8.75M in Q1 2022.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.